| Usefulness of procalcitonin levels in community-acquired pneumonia according to the patients outcome research team pneumonia severity index M Masia, F Gutierrez, C Shum, S Padilla, JC Navarro, E Flores, ... Chest 128 (4), 2223-2229, 2005 | 309 | 2005 |
| Prediction of neuropsychiatric adverse events associated with long-term efavirenz therapy, using plasma drug level monitoring F Gutiérrez, A Navarro, S Padilla, R Antón, M Masiá, J Borrás, ... Clinical infectious diseases 41 (11), 1648-1653, 2005 | 287 | 2005 |
| The influence of age and gender on the population-based incidence of community-acquired pneumonia caused by different microbial pathogens F Gutiérrez, M Masiá, C Mirete, B Soldán, JC Rodríguez, S Padilla, ... Journal of infection 53 (3), 166-174, 2006 | 270 | 2006 |
| Mental health impact of COVID-19 pandemic on Spanish healthcare workers L García-Fernández, V Romero-Ferreiro, PD López-Roldán, S Padilla, ... Psychological medicine 52 (1), 195-197, 2022 | 167 | 2022 |
| Mental health in elderly Spanish people in times of COVID-19 outbreak L García-Fernández, V Romero-Ferreiro, PD López-Roldán, S Padilla, ... The American Journal of Geriatric Psychiatry 28 (10), 1040-1045, 2020 | 152 | 2020 |
| Gender differences in emotional response to the COVID‐19 outbreak in Spain L García‐Fernández, V Romero‐Ferreiro, S Padilla, ... Brain and behavior 11 (1), e01934, 2021 | 142 | 2021 |
| Epidemiology of community-acquired pneumonia in adult patients at the dawn of the 21st century: a prospective study on the Mediterranean coast of Spain F Gutiérrez, M Masia, JC Rodriguez, C Mirete, B Soldán, S Padilla, ... Clinical microbiology and infection 11 (10), 788-800, 2005 | 121 | 2005 |
| Antibody response to SARS-CoV-2 is associated with long-term clinical outcome in patients with COVID-19: a longitudinal study J García-Abellán, S Padilla, M Fernández-González, JA García, V Agulló, ... Journal of clinical immunology 41 (7), 1490-1501, 2021 | 112 | 2021 |
| Risk, predictors, and mortality associated with non-AIDS events in newly diagnosed HIV-infected patients: role of antiretroviral therapy M Masiá, S Padilla, D Alvarez, JC Lopez, I Santos, V Soriano, ... Aids 27 (2), 181-189, 2013 | 110 | 2013 |
| Lopinavir plasma concentrations and changes in lipid levels during salvage therapy with lopinavir/ritonavir-containing regimens F Gutiérrez, S Padilla, A Navarro, M Masiá, I Hernández, J Ramos, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 33 (5), 594-600, 2003 | 108 | 2003 |
| A bibliometric analysis of tuberculosis research indexed in PubMed, 1997–2006 JM Ramos, S Padilla, M Masia, F Gutierrez The International Journal of Tuberculosis and Lung Disease 12 (12), 1461-1468, 2008 | 99 | 2008 |
| Influence of antiretroviral therapy on oxidative stress and cardiovascular risk: a prospective cross-sectional study in HIV-infected patients M Masiá, S Padilla, E Bernal, MV Almenar, J Molina, I Hernández, ... Clinical Therapeutics 29 (7), 1448-1455, 2007 | 97 | 2007 |
| Patients' characteristics and clinical implications of suboptimal CD4 T-cell gains after 1 year of successful antiretroviral therapy F Gutiérrez, S Padilla, M Masiá, JA Iribarren, S Moreno, P Viciana, ... Current HIV research 6 (2), 100-107, 2008 | 96 | 2008 |
| Increasing incidence of hepatocellular carcinoma in HIV-infected patients in Spain N Merchante, E Merino, J López-Aldeguer, F Jover, ... Clinical Infectious Diseases 56 (1), 143-150, 2013 | 95 | 2013 |
| Contribution of interferon gamma release assays testing to the diagnosis of latent tuberculosis infection in HIV-infected patients: a comparison of QuantiFERON-TB Gold In Tube … JM Ramos, C Robledano, M Masiá, S Belda, S Padilla, JC Rodríguez, ... BMC infectious diseases 12, 1-10, 2012 | 91 | 2012 |
| Community-acquired pneumonia of mixed etiology: prevalence, clinical characteristics, and outcome F Gutiérrez, M Masia, JC Rodriguez, C Mirete, B Soldán, S Padilla, ... European Journal of Clinical Microbiology and Infectious Diseases 24, 377-383, 2005 | 89 | 2005 |
| Impact of interleukin-6 blockade with tocilizumab on SARS-CoV-2 viral kinetics and antibody responses in patients with COVID-19: A prospective cohort study M Masiá, M Fernández-González, S Padilla, P Ortega, JA García, V Agulló, ... EBioMedicine 60, 2020 | 78 | 2020 |
| The role of C-reactive protein as a marker for cardiovascular risk associated with antiretroviral therapy in HIV-infected patients M Masiá, E Bernal, S Padilla, ML Graells, I Jarrín, MV Almenar, J Molina, ... Atherosclerosis 195 (1), 167-171, 2007 | 76 | 2007 |
| Early changes in parathyroid hormone concentrations in HIV-infected patients initiating antiretroviral therapy with tenofovir M Masiá, S Padilla, C Robledano, N López, JM Ramos, F Gutiérrez AIDS research and human retroviruses 28 (3), 242-246, 2012 | 75 | 2012 |
| High-density lipoprotein cholesterol in HIV-infected patients: evidence for an association with HIV-1 viral load, antiretroviral therapy status, and regimen composition E Bernal, M Masiá, S Padilla, F Gutiérrez AIDS patient care and STDs 22 (7), 569-575, 2008 | 75 | 2008 |
